WP
ABMD

WealthPLAN Partners’s Abiomed Inc ABMD Stock Holding History

WealthPLAN Partners’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-50
Closed -$6.17K – 451
2017
Q1 		$6.17K Buy
+50
New +$5.8K 0.02% 320
2016
Q3 		$12.7K Sell
100
-100
-50% -$12K ﹤0.01% 560
2016
Q2 		$10.9K Buy
+200
New +$19.9K ﹤0.01% 1699

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

WealthPLAN Partners's ABMD Position: Q2 2017 in Review

WealthPLAN Partners sold out of Abiomed Inc (ABMD) in Q2 2017, closing a stake of 50 shares — an estimated $6.17K sold.

WealthPLAN Partners first reported a position in ABMD in Q2 2016 and held it in 3 quarters. The position peaked at $12.7K in Q3 2016. 303 funds tracked by Wall St. Rank hold ABMD as of Q2 2017.

  • WealthPLAN Partners reported no remaining Abiomed Inc position as of Q2 2017 after selling out during the quarter.
  • WealthPLAN Partners sold 50 Abiomed Inc shares in Q2 2017, an estimated $6.17K.
  • WealthPLAN Partners first reported a position in Abiomed Inc in Q2 2016 and held it in 3 quarters.
  • WealthPLAN Partners's Abiomed Inc position peaked at $12.7K in Q3 2016.
  • 303 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2017.

Based on WealthPLAN Partners's 13F filing for Q2 2017, filed 11 Aug 2017.